Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is rapidly gaining attention in the biotech sector, thanks to a compelling 80% potential upside and favorable analyst ratings. As a clinical-stage biopharmaceutical company, ORIC..
Emergent BioSolutions Inc. (NYSE: EBS) stands out in the healthcare sector, particularly in the niche of drug manufacturers specializing in both specialty and generic products. With a market capitalization of..
AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, has been making waves with its innovative medical technologies aimed at treating peripheral vascular disease and enhancing oncology and..
In the dynamic landscape of biotechnology, Celcuity Inc. (NASDAQ: CELC) stands out as a promising player with significant growth potential. With its focus on developing targeted therapies for solid tumors,..
Standard BioTools Inc. (NASDAQ: LAB) presents a compelling opportunity for investors looking to explore the healthcare sector, particularly within the medical devices industry. With its current stock price standing at..
LifeMD, Inc. (NASDAQ: LFMD), a key player in the healthcare sector, is making waves in the health information services industry. Operating as a direct-to-patient telehealth company in the United States,..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands out in the biotechnology sector with a market capitalization of $780.39 million and a focus on addressing unmet medical needs in oncology. As a..
Investors eyeing biotechnology companies with high-risk, high-reward potential may find Upstream Bio, Inc. (NASDAQ: UPB) intriguing. The company, headquartered in Waltham, Massachusetts, is at the forefront of developing innovative treatments..
Cogent Biosciences, Inc. (NASDAQ: COGT), a burgeoning player in the biotechnology sector, is capturing attention due to its innovative approach to precision therapies for genetically defined diseases. As of now,..
Cel-Sci Corporation (CVM), a clinical-stage biotechnology company, is capturing the attention of astute investors with its ambitious potential upside of 9,737.05%. Headquartered in Vienna, Virginia, Cel-Sci stands at the forefront..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a trailblazer in the biotechnology sector, offering innovative solutions through its platform for cell programming. Despite facing a challenging financial landscape, the company’s..
Tilray Brands, Inc. (NASDAQ: TLRY), a key player in the healthcare sector, specializes in the cultivation and distribution of medical cannabis products globally. With its market capitalization standing at $424.15..
Kamada Ltd. (NASDAQ: KMDA), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, has been turning heads with its impressive growth potential. Headquartered..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) commands attention in the biotechnology sector, driven by its pioneering work in gene editing. The company is carving a niche in developing curative genome editing..
Regulus Therapeutics Inc. (NASDAQ: RGLS), a specialist in biotechnology, is sailing through the dynamic waters of the healthcare sector with its innovative focus on microRNA-targeted therapies. Headquartered in San Diego,..
SIGA Technologies Inc. (NASDAQ: SIGA) stands as an intriguing player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With its headquarters in New York, the..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is making waves in the healthcare sector with its impressive portfolio of treatments targeting rare diseases. Based out of Deer Park, Illinois, Eton focuses on..
Butterfly Network, Inc. (NASDAQ: BFLY), a healthcare company operating in the medical devices industry, has captured the attention of investors with its innovative approach to ultrasound imaging solutions. Based in..
Prothena Corporation plc (PRTA), a prominent player in the biotechnology sector, has been making waves with its innovative approach to treating diseases caused by protein dysregulation. Based in Dublin, Ireland,..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology sector with its focus on developing therapies for autoimmune diseases and cancer. Headquartered in Cambridge, Massachusetts, this clinical-stage biopharmaceutical firm..
